Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01090141Phase 4Completed
Phase 4, randomised, open-label trial of micafungin in fungal infection (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Serum Clearance at 24 hours. Started Nov 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01090141.